Alembic Pharma gets USFDA nod for Tretinoin cream

15 Jun 2026via IndiabloomsSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Alembic Pharma gets USFDA nod for Tretinoin cream
Alembic Pharmaceuticals has received final approval from the USFDA for Tretinoin Cream USP, 0.05%. The product is a generic version of Avita Cream, used for acne treatment. This approval expands Alembic’s dermatology portfolio in the US market.

📊 STOCKS: ALPH | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #USFDA

#USFDA#approval#dermatology#generic

Stocks mentioned

APLLTDAPLLTD

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →